China Pharma Holdings CPHI
NYSE CPHI
$0.67 -0.05 (-6.91%)
As of: Sep 29, 2026 · 3:57 PM EDT

China Pharma Holdings (CPHI) EV to EBITDA (2011 - 2023)

Updated

China Pharma Holdings' (CPHI) EV to EBITDA stood at 330.77 in Q4 2023.

Analysis

China Pharma Holdings (CPHI) EV to EBITDA (2011 - 2023) Analysis & Trends

Starting with Q2 2011, China Pharma Holdings' EV to EBITDA history includes 14 quarters.

  • Across earlier years, EV to EBITDA came in at 78.59 in FY2021 (-57.4%) and 184.36 in FY2020.
  • The Q4 2023 figure is the highest quarterly EV to EBITDA since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 China Pharma Holdings 29.58 Mn 28.46 Mn 83,566.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 330.77
Mar 31, 2022 594.66
Dec 31, 2021 78.59
Mar 31, 2021 747.53
Dec 31, 2020 184.36
Mar 31, 2016 9.33
Mar 31, 2013 12.63
Dec 31, 2012 0.64
Sep 30, 2012 0.83
Jun 30, 2012 0.57
Mar 31, 2012 1.24
Dec 31, 2011 1.08
Sep 30, 2011 1.43
Jun 30, 2011 3.51
API Access

China Pharma Holdings EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CPHI&period=max&api_key=YOUR_API_KEY